icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Tue 27 Oct 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

الأخبار العلمية

sfsd
icon 2025-12-18

SFDA Approves the Registration of “Qfitlia” for Hemophilia A or B

The Saudi Food and Drug Authority (SFDA) has approved the registration of Qfitlia (Fitusiran) for routine prophylaxis to prevent or reduce the...
More
58
icon 2025-10-09

SFDA Approves the Registration of Qalsody for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

The Saudi Food and Drug Authority (SFDA), has approved the registration of Qalsody (tofersen) for the treatment of adults with amyotrophic lateral...
More
E
icon 2026-08-11

SFDA Becomes First Regulatory Authority Globally to Approve the Registration of 'ZENBEXUS' for the Treatment of Multiple Myeloma in Adults

The Saudi Food and Drug Authority (SFDA) has approved the registration of ZENBEXUS (iberdomide) for the treatment of adult patients with relapsed or...
More
�تسجيل مستحضر فريهيمجو_en.jpg.jpeg
icon 2026-09-14

SFDA Becomes First Regulatory Authority Globally to Approve the Registration of "Frehemgo" for the Prevention of Bleeding Episodes in Patients with Haemophilia A

The Saudi Food and Drug Authority (SFDA) has approved the registration of Frehemgo (denecimig) for the routine prophylaxis of bleeding episodes in...
More
4
icon 2026-03-10

SFDA Grants Breakthrough Designation to "Bemlayo" for Adults with Obesity or Overweight

The Saudi Food and Drug Authority (SFDA) has granted Eli Lilly Breakthrough designation to Bemlayo (Orforglipron), which is indicated as an adjunct to...
More
h.jpg
icon 2026-10-01

SFDA Grants Breakthrough Designation to "Infilbray" for the Treatment of Patients with Type 3 Gaucher Disease

The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to Infilbray (venglustat), developed by Sanofi, for the treatment of...
More